skip to main content
Show Results with:

Results 1 - 10 of 32  for Everything in this catalogue

results 1 2 3 4 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Management of toxicities of immune checkpoint inhibitors

Spain, Lavinia; Diem, Stefan; Larkin, James

Cancer treatment reviews. Volume 44 (2016); pp 51-60 -- Elsevier

Online access

2
Material Type:
Article
Add to My workspace

Management of toxicities of immune checkpoint inhibitors

Spain, Lavinia; Diem, Stefan; Larkin, James

Elsevier -- 2016

Online access

3
Material Type:
Article
Add to My workspace

BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma

Richman, Juliet et al.

Expert opinion on pharmacotherapy. Volume 16:Number 9 (2015); pp 1285-1297 -- Taylor & Francis

Online access

4
Material Type:
Article
Add to My workspace

Prognostic score for patients with advanced melanoma treated with ipilimumab

Diem, Stefan et al.

European journal of cancer. Volume 51:Issue 18 (2015, December); pp 2785-2791 -- Elsevier

Online access

5
Material Type:
Article
Add to My workspace

Prognostic score for patients with advanced melanoma treated with ipilimumab

Diem, Stefan et al.

European journal of cancer -- Elsevier -- Volume: 51 18; (pages 2785-2791) -- 2015

Online access

6
Material Type:
Article
Add to My workspace

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade

Hitz, Felicitas et al.

Hematological oncology. Volume 32:Issue 4 (2014, December); pp 192-196 -- John Wiley & Sons

Online access

7
Material Type:
Article
Add to My workspace

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111 (2017); pp 176-181 -- Elsevier Science Pub. Co

Online access

8
Material Type:
Article
Add to My workspace

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111: (2017, September); pp 176-181 -- Elsevier Science Pub. Co

Online access

9
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107 (2019); pp 8-14 -- Elsevier

Online access

10
Material Type:
Article
Add to My workspace

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

Diem, Stefan et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 39:Issue 9 (2016, November/December) -- Lippincott Williams & Wilkins

Online access

Results 1 - 10 of 32  for Everything in this catalogue

results 1 2 3 4 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (23)
  2. Online: Reading Room only  (19)
  3. Purchase a copy  (15)
  4. Refine further open sub menu

Material type 

  1. Articles  (31)
  2. Books  (1)
  3. Refine further open sub menu

Creation date 

From To
  1. Before2014  (1)
  2. 2014To2014  (2)
  3. 2015To2015  (3)
  4. 2016To2017  (17)
  5. After 2017  (9)
  6. Refine further open sub menu

Language 

  1. German  (1)
  2. English  (1)
  3. Refine further open sub menu

Additional Features 

  1. Abstract  (28)
  2. No Abstract  (3)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait